This is a preview of subscription content, log in via an institution to check access.
Reference
Kohn CG, et al. Cost-Effectiveness of Ranolazine Added to Standard-of-Care Treatment in Patients With Chronic Stable Angina Pectoris. American Journal of Cardiology : 31 Jan 2014. Available from: URL: http://dx.doi.org/10.1016/j.amjcard.2014.01.407
Additional information
* The study was supported by Gilead Sciences, US.
** Efficacy of Ranolazine in Chronic Angina
Rights and permissions
About this article
Cite this article
Ranolazine added to anti-anginals good value for money. PharmacoEcon Outcomes News 698, 8 (2014). https://doi.org/10.1007/s40274-014-1110-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1110-x